ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 62 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2019. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $816,000 | -1.3% | 228,000 | +5.6% | 0.05% | -8.9% |
| Q4 2018 | $827,000 | +24.9% | 216,000 | +208.6% | 0.06% | +43.6% |
| Q3 2018 | $662,000 | -10.5% | 70,000 | -67.4% | 0.04% | -42.6% |
| Q3 2016 | $740,000 | -1.1% | 215,000 | 0.0% | 0.07% | -23.6% |
| Q2 2016 | $748,000 | -15.8% | 215,000 | 0.0% | 0.09% | -28.2% |
| Q1 2016 | $888,000 | -32.2% | 215,000 | 0.0% | 0.12% | -39.2% |
| Q3 2015 | $1,309,000 | – | 215,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |